Clinical Trial: The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Observational




Official Title:

Brief Summary: The purpose of this study is to determine if cannabidiol (CBD) obtained via the state of Minnesota reduces seizures in patients with severe intractable epilepsy (Dravet Syndrome or Lennox Gastaut Syndrome), and to measure blood levels of CBD to help determine CBD concentration-response characteristics.